Patent details
EP2687596 Title: Factor VII polypeptides that are modified and uses thereof
Basic Information
- Publication number:
- EP2687596
- PCT Application Number:
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP131621666
- PCT Publication Number:
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- Factor VII polypeptides that are modified and uses thereof
- French Title of Invention:
- Polypeptides du facteur VII modifiés et leurs utilisations
- German Title of Invention:
- Modifizierte Faktor-VII-Polypeptide und Verwendungen dafür
- SPC Number:
Dates
- Filing date:
- 10/04/2009
- Grant date:
- 06/01/2016
- EP Publication Date:
- 06/01/2016
- PCT Publication Date:
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 22/01/2014
- EP B1 Publication Date:
- 06/01/2016
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 10/04/2016
- Expiration date:
- 10/04/2029
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 10/04/2009
- Name:
- Catalyst Biosciences Inc.
- Address:
- 260 Littlefield Avenue, South San Francisco, CA 94080, United States (US)
Agent
- Name:
- OFFICE FREYLINGER S.A.
- From:
- 27/01/2016
- Address:
- Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
- To:
Inventor
1
- Name:
- Madison Edwin
- Address:
- United States (US)
2
- Name:
- Thanos Christopher
- Address:
- United States (US)
Priority
- Priority Number:
- 124021 P
- Priority Date:
- 11/04/2008
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- C12N 9/64;
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|